Published in Environ Health Perspect on February 13, 2012
The National Birth Defects Prevention Study: A review of the methods. Birth Defects Res A Clin Mol Teratol (2015) 1.28
Maternal smoking during pregnancy and the risk of congenital heart defects in offspring: a systematic review and metaanalysis. Pediatr Cardiol (2012) 0.92
Search query data to monitor interest in behavior change: application for public health. PLoS One (2012) 0.87
Maternal occupational exposure to polycyclic aromatic hydrocarbons and congenital heart defects among offspring in the national birth defects prevention study. Birth Defects Res A Clin Mol Teratol (2012) 0.86
The shared pathoetiological effects of particulate air pollution and the social environment on fetal-placental development. J Environ Public Health (2014) 0.82
Maternal periconceptional occupational exposure to pesticides and selected musculoskeletal birth defects. Int J Hyg Environ Health (2013) 0.81
Spatial analysis of gastroschisis in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2015) 0.78
Levels of PAH-DNA adducts in placental tissue and the risk of fetal neural tube defects in a Chinese population. Reprod Toxicol (2013) 0.77
A case-control study of maternal bathing habits and risk for birth defects in offspring. Environ Health (2013) 0.77
Maternal lifestyle factors in pregnancy and congenital heart defects in offspring: review of the current evidence. Ital J Pediatr (2014) 0.75
Etiology of gastroschisis. J Neonatal Surg (2012) 0.75
Maternal occupational exposure to polycyclic aromatic hydrocarbons and craniosynostosis among offspring in the national birth defects prevention study. Birth Defects Res A Clin Mol Teratol (2015) 0.75
Levels of PAH-DNA adducts in cord blood and cord tissue and the risk of fetal neural tube defects in a Chinese population. Neurotoxicology (2014) 0.75
Maternal and community predictors of gastroschisis and congenital diaphragmatic hernia in Canada. Pediatr Surg Int (2015) 0.75
Transplacental transfer of 2-naphthol in human placenta. Toxicol Rep (2015) 0.75
The National Birth Defects Prevention Study. Public Health Rep (2001) 5.50
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc (1987) 3.05
Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol (2004) 2.50
Identifying critical windows of exposure for children's health. Environ Health Perspect (2000) 2.32
Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet (2006) 2.15
Synergistic embryotoxicity of polycyclic aromatic hydrocarbon aryl hydrocarbon receptor agonists with cytochrome P4501A inhibitors in Fundulus heteroclitus. Environ Health Perspect (2004) 1.70
Etiologic heterogeneity of neural tube defects: clues from epidemiology. Am J Epidemiol (1982) 1.66
Occupation and bladder cancer among men in Western Europe. Cancer Causes Control (2003) 1.54
Development of gastroschisis: review of hypotheses, a novel hypothesis, and implications for research. Am J Med Genet A (2007) 1.51
Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies--a review. Int J Hyg Environ Health (2008) 1.50
Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proc Natl Acad Sci U S A (2011) 1.38
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann Oncol (2006) 1.36
Monitoring human occupational and environmental exposures to polycyclic aromatic compounds. Ann Occup Hyg (2003) 1.31
Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives in Swiss mice. Cancer Res (1986) 1.20
Bayesian methods for correcting misclassification: an example from birth defects epidemiology. Epidemiology (2009) 1.19
The murine Ah locus: in utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. Teratology (1979) 1.18
The embryology of body wall closure: relevance to gastroschisis and other ventral body wall defects. Am J Med Genet C Semin Med Genet (2008) 1.09
Inter-rater reliability of assessed prenatal maternal occupational exposures to solvents, polycyclic aromatic hydrocarbons, and heavy metals. J Occup Environ Hyg (2011) 1.06
Effects of the polycyclic aromatic hydrocarbon heterocycles, carbazole and dibenzothiophene, on in vivo and in vitro CYP1A activity and polycyclic aromatic hydrocarbon-derived embryonic deformities. Environ Toxicol Chem (2005) 1.06
Maternal occupation and the risk of birth defects: an overview from the National Birth Defects Prevention Study. Occup Environ Med (2010) 1.06
Detection of benzo[a]pyrene-DNA adducts in human placenta and umbilical cord blood. Hum Exp Toxicol (1997) 1.05
Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A (2009) 1.05
Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis (1998) 1.05
Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis (1994) 1.05
Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg (2009) 1.04
Parental occupation, occupational exposure to solvents and polycyclic aromatic hydrocarbons and risk of childhood brain tumors (Italy, France, Spain) Cancer Causes Control (1997) 1.04
Etiologic heterogeneity of neural tube defects. II. Clues from family studies. Am J Hum Genet (1982) 1.04
Increasing prevalence of gastroschisis repairs in the United States: 1996-2003. J Pediatr Surg (2007) 1.02
Polycyclic aromatic hydrocarbons in placenta, maternal blood, umbilical cord blood and milk of Indian women. Hum Exp Toxicol (1995) 1.01
Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol (1980) 1.01
Biomarkers of exposure to combustion by-products in a human population in Shanxi, China. J Expo Sci Environ Epidemiol (2009) 1.00
Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: a multicenter study in Europe. Occup Environ Med (2009) 0.98
First trimester maternal medication use in relation to gastroschisis. Teratology (1992) 0.96
The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study. Occup Environ Med (2005) 0.96
Health risk assessment of urban suspended particulate matter with special reference to polycyclic aromatic hydrocarbons: a review. Rev Environ Health (2001) 0.95
A case control population-based study investigating smoking as a risk factor for gastroschisis in Utah, 1997-2005. Birth Defects Res A Clin Mol Teratol (2008) 0.95
Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse. Teratology (1977) 0.93
Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits. Birth Defects Res C Embryo Today (2010) 0.93
Parental lead exposure and total anomalous pulmonary venous return. Birth Defects Res A Clin Mol Teratol (2004) 0.91
Exposure to polycyclic aromatic hydrocarbons (PAHs), mutagenic aldehydes, and particulate matter in Norwegian a la carte restaurants. Ann Occup Hyg (2009) 0.87
Gastroschisis prevalence in Texas 1999-2003. Birth Defects Res A Clin Mol Teratol (2010) 0.87
Gastroschisis: a gene-environment model involving the VEGF-NOS3 pathway. Am J Med Genet C Semin Med Genet (2008) 0.84
Differential metabolism of benzo[alpha]pyrene in vitro by human placental tissues exposed to active maternal cigarette smoke. Birth Defects Res B Dev Reprod Toxicol (2007) 0.82
Modified Japanese medaka embryo-larval bioassay for rapid determination of developmental abnormalities. Arch Environ Contam Toxicol (2006) 0.82
Modulation of the embryotoxicity and cytotoxicity elicited by 7-hydroxy-2-acetylaminofluorene and acetaminophen via deacetylation. Toxicol Appl Pharmacol (1989) 0.79
Semi-volatiles in mainstream smoke delivery from select charcoal-filtered cigarette brand variants. Tob Control (2010) 0.79
Teratogenic effects of benzo[a]pyrene in developing chick embryo. Toxicol Lett (1988) 0.77
Workplace hazards to women's reproductive health. Minn Med (2007) 0.77
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med (2007) 9.48
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Ambient air pollution and risk of birth defects in Southern California. Am J Epidemiol (2002) 3.43
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol (2011) 3.42
Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25
Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr (2009) 2.90
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm Genome (2012) 2.65
Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med (2009) 2.45
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod (2008) 2.38
Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr (2006) 2.36
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Neural tube defects and folate: case far from closed. Nat Rev Neurosci (2006) 2.30
A new partner for the international knockout mouse consortium. Cell (2007) 2.23
Maternal exposure to ambient levels of benzene and neural tube defects among offspring: Texas, 1999-2004. Environ Health Perspect (2010) 2.16
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
Large-scale gene trapping in C57BL/6N mouse embryonic stem cells. Genome Res (2008) 2.08
Occupational risk factors and asthma among health care professionals. Am J Respir Crit Care Med (2006) 2.04
Sharing prescription medication among teenage girls: potential danger to unplanned/undiagnosed pregnancies. Pediatrics (2003) 1.99
GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet A (2003) 1.94
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Alcohol consumption by women before and during pregnancy. Matern Child Health J (2008) 1.94
Maternal periconceptional vitamins: interactions with selected factors and congenital anomalies? Epidemiology (2002) 1.93
Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol (2009) 1.93
The planar cell polarity effector Fuz is essential for targeted membrane trafficking, ciliogenesis and mouse embryonic development. Nat Cell Biol (2009) 1.90
Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol (2011) 1.89
The continuing challenge of understanding, preventing, and treating neural tube defects. Science (2013) 1.86
Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A (2005) 1.82
Residential mobility patterns and exposure misclassification in epidemiologic studies of birth defects. J Expo Sci Environ Epidemiol (2006) 1.79
Differences in exposure assignment between conception and delivery: the impact of maternal mobility. Paediatr Perinat Epidemiol (2010) 1.76
118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet (2009) 1.74
Reduced risks of neural tube defects and orofacial clefts with higher diet quality. Arch Pediatr Adolesc Med (2011) 1.73
Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A (2014) 1.70
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ (2015) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology (2004) 1.63
A mouse model of hereditary folate malabsorption: deletion of the PCFT gene leads to systemic folate deficiency. Blood (2011) 1.62
Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol (2008) 1.62
NAT2 variation and idiopathic talipes equinovarus (clubfoot). Am J Med Genet A (2007) 1.57
Comparison of residential geocoding methods in population-based study of air quality and birth defects. Environ Res (2006) 1.57
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Comparison of trihalomethanes in tap water and blood. Environ Sci Technol (2002) 1.55
Schizencephaly: heterogeneous etiologies in a population of 4 million California births. Am J Med Genet A (2005) 1.55
Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol (2008) 1.53
Mid-pregnancy cotinine and risks of orofacial clefts and neural tube defects. J Pediatr (2008) 1.52
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis (2002) 1.51
In vitro fertilization is associated with an increase in major birth defects. Fertil Steril (2005) 1.51
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
Match rate and positional accuracy of two geocoding methods for epidemiologic research. Ann Epidemiol (2006) 1.48
Identification of novel candidate gene loci and increased sex chromosome aneuploidy among infants with conotruncal heart defects. Am J Med Genet A (2013) 1.48
Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort. Epidemiology (2006) 1.46
Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol (2014) 1.45
Assessing maintenance of evaporative cooling systems in legionellosis outbreaks. J Occup Environ Hyg (2011) 1.45
Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics (2010) 1.43
Diacylglycerol kinase K variants impact hypospadias in a California study population. J Urol (2012) 1.43
Epidemiologic characteristics of congenital diaphragmatic hernia among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol (2006) 1.43
Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. MMWR Morb Mortal Wkly Rep (2016) 1.43
Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. Arch Neurol (2010) 1.42
Assessment of occupational cosmic radiation exposure of flight attendants using questionnaire data. Aviat Space Environ Med (2011) 1.42
Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007. Paediatr Perinat Epidemiol (2013) 1.40
Candidate gene sequencing of LHX2, HESX1, and SOX2 in a large schizencephaly cohort. Am J Med Genet A (2010) 1.40